Overview

Update
Status
Acquired by on April 20, 2015
Total Equity Funding
$109.4M in 4 Rounds from 10 Investors
Headquarters:
Menlo Park, CA
Description:
Spinal Modulation is a medical device company developing spinal cord neurostimulator systems for the treatment of chronic intractable pain.
Founders:
Categories:
Medical Device, Health Care, Neuroscience
Website:
http://www.spinalmodulation.com

Company Details

Update

Spinal Modulation, Inc. provides medical devices research and development services. The company is based in Menlo Park, California.

According to the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain, as defined by the International Association for the Study of Pain, is prevalent in 10 to 13% of the adult population. Limited treatment options exist for these patients and the burden to the healthcare system is unsustainable.

The Spinal Modulation AxiumTM Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.

By stimulating the DRG, therapy can be adjusted to cover either broad or specific areas of pain throughout the torso and legs, while limiting uncomfortable postural effects typically experienced with other spinal cord stimulators.

Funding Rounds (5) - $111.27M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2013$45M / Series E1
Mar, 2013$1.87M / Debt Financing0
Jun, 2011$30M / Series D8
Nov, 2009$27.4M / Series C7
Jan, 2006$7M / Series A3

Current Team (9)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Office

    1135 O'Brien DR

    Menlo Park, CA 94025

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos